| EMA number | EMEA/H/C/002398 |
| ATC code | R03DX07 |
| Authorisation | 28 February 2011 |
| Withdrawn | 11 January 2018 |
| Revision | 9 |
Daliresp is indicated for maintenance treatment of severe chronic obstructive pulmonary disease (COPD) (FEV1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis in adult patients with a history of frequent exacerbations as add-on to bronchodilator treatment.